GSA Capital Partners’s Rentokil RTO Stock Holding History

GSA Capital Partners’s Portfolio RTO Stock Details RTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,598	Closed	-$948K	–	1865
2023 Q3	$948K	Buy	25,598 +11,133	+77%	+$425K	0.08%	429
2023 Q2	$564K	Buy	14,465 +7,200	+99%	+$282K	0.06%	665
2023 Q1	$265K	Buy	+7,265	New	+$229K	0.03%	1100

Other funds holding RTO

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return

GSA Capital Partners's RTO Position: Q4 2023 in Review

GSA Capital Partners sold out of Rentokil (RTO) in Q4 2023, closing a stake of 25,598 shares — an estimated $948K sold.

GSA Capital Partners first reported a position in RTO in Q1 2023 and held it in 3 quarters. The position peaked at $948K in Q3 2023. 188 funds tracked by Wall St. Rank hold RTO as of Q4 2023.

GSA Capital Partners reported no remaining Rentokil position as of Q4 2023 after selling out during the quarter.
GSA Capital Partners sold 25,598 Rentokil shares in Q4 2023, an estimated $948K.
GSA Capital Partners first reported a position in Rentokil in Q1 2023 and held it in 3 quarters.
GSA Capital Partners's Rentokil position peaked at $948K in Q3 2023.
188 funds tracked by Wall St. Rank held Rentokil as of Q4 2023.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.